Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
TenNor Therapeutics logo — Clinical-stage biotechnology company dedicated to discovery...

TenNor Therapeutics

Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.

Founded 2013 China Suzhou, China 5 employees Series D Total: $355.00M Biotechnology, Health and Wellness

General Information

Company Name TenNor Therapeutics
Founded Year 2013
Location China Suzhou, China +1
Employees 5
Industries Biotechnology, Health and Wellness
Funding Stage Series D
Social

Get notified when TenNor Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About TenNor Therapeutics

TenNor Therapeutics is a clinical-stage biotechnology company founded in 2013. The company's slogan reflects its dedication to the discovery and development of therapeutics in infectious diseases. Headquartered in China, the company has recently received a significant CNY66.00M Series D investment on 21 December 2022. This latest investment was made by Yanchuang Capital and Broad Resources. TenNor Therapeutics' innovative approach and focus on addressing unmet medical needs in the field of infectious diseases make it an intriguing prospect for venture capital consideration.

Taxonomy: therapeutics, infectious diseases, drug development, clinical-stage, pharmaceuticals

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D •••••• 2
Investor
•••• •••• 		21 Dec 2022
Series D •••••• 8
Investor Investor Investor Investor
•••• •••• 		30 Mar 2022
Series B •••••• - 19 Sep 2016
Grant •••••• - 05 Feb 2016

FAQ About TenNor Therapeutics

Clinical-stage biotechnology company dedicated to discovery and development of therapeutics in infectious diseases.
TenNor Therapeutics was founded in 2013.
TenNor Therapeutics is headquartered in Suzhou, China.
TenNor Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
TenNor Therapeutics has approximately 5 employees.
TenNor Therapeutics has completed 4 funding rounds, raising a total of $355.00M. The latest funding stage is Series D.

We're actively collecting intelligence on TenNor Therapeutics.

Track TenNor Therapeutics to get notified

Don't just browse. Track.

Signal Tracker monitors TenNor Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy